Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Psybio Therapeutics Corp (PSYBF)

Psybio Therapeutics Corp (PSYBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PSYBF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0001 unch
on 06/20/24
0.0085 -98.82%
on 06/13/24
-0.0060 (-98.36%)
since 05/17/24
3-Month
0.0001 unch
on 06/20/24
0.0085 -98.82%
on 06/13/24
-0.0040 (-97.56%)
since 03/20/24
52-Week
0.0001 unch
on 06/20/24
0.0267 -99.63%
on 07/06/23
-0.0192 (-99.48%)
since 06/20/23

Most Recent Stories

More News
PsyBio Therapeutics Awarded Approval to Manufacture Biosynthetic Tryptamines at Scale

PsyBio continues to develop psycho-targeted, biosynthesized tryptamines and with this authorization becomes the first biotechnology company to obtain government sanctioned, formal, written authorization...

PSYBF : 0.0001 (-98.82%)
PSYB.VN : 0.010 (+42.86%)
PsyBio Announces Closing of Third Tranche of Private Placement

Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - April 20, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company...

PSYBF : 0.0001 (-98.82%)
PSYB.VN : 0.010 (+42.86%)
PsyBio Announces Panel Participation on NextGen Psychedelics at Benzinga Cannabis Capital Conference

Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - April 6, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company...

PSYBF : 0.0001 (-98.82%)
PSYB.VN : 0.010 (+42.86%)
PsyBio Therapeutics Founder Wins Best Pitch at Investment Summit

Prestigious award recognizes innovative company as a leading player in the emerging field of psychedelic medicineMiami, Florida--(Newsfile Corp. - March 13, 2023) - Evan Levine, CEO and Founder of PsyBio...

PSYBF : 0.0001 (-98.82%)
PSYB.VN : 0.010 (+42.86%)
PsyBio Announces Closing of Second Tranche of Private Placement

Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - January 13, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology...

PSYBF : 0.0001 (-98.82%)
PSYB.VN : 0.010 (+42.86%)
PsyBio Announces Appointment of Ian Wisenberg to Board of Directors

Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - January 10, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology...

PSYB.VN : 0.010 (+42.86%)
PSYBF : 0.0001 (-98.82%)
PsyBio Announces Closing of First Tranche of Private Placement Led by the Chairman and Chief Executive Officer with Participation from the Entire Board of Directors and Management Team and Provides Corporate Update

Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - January 5, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology...

PSYB.VN : 0.010 (+42.86%)
PSYBF : 0.0001 (-98.82%)
PsyBio Therapeutics Takes Initial Step to Help Protect the Sonoran Desert Toad as it Files Three New Provisional Patent Applications, Including Intellectual Property Protection for the Biosynthetic Production of 5-MeO-DMT

/CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company focused upon...

PSYBF : 0.0001 (-98.82%)
PsyBio Therapeutics Files Four U.S. Patent Cooperation Treaty (PCT) Patent Applications Further Expanding Its Patent Portfolio

/CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company focused upon...

PSYBF : 0.0001 (-98.82%)
PsyBio Therapeutics Announces Non-Brokered Private Placement Financing

/CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company focused on...

PSYBF : 0.0001 (-98.82%)

Key Turning Points

3rd Resistance Point 0.0001
2nd Resistance Point 0.0001
1st Resistance Point 0.0001
Last Price 0.0001
1st Support Level 0.0001
2nd Support Level 0.0001
3rd Support Level 0.0001

See More

52-Week High 0.0267
Fibonacci 61.8% 0.0165
Fibonacci 50% 0.0134
Fibonacci 38.2% 0.0103
Last Price 0.0001
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar